Metoprolol vs Semaglutide: side-by-side comparison
Metoprolol (Beta-1 selective adrenergic blocker) and Semaglutide (GLP-1 receptor agonist) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Metoprolol | Semaglutide |
|---|---|---|
| Therapeutic class | Beta-1 selective adrenergic blocker | GLP-1 receptor agonist |
| CAS | 51384-51-1 | 910463-68-2 |
| ATC | C07AB02 | A10BJ06 |
| Molecular weight | 267.36 g/mol | 4113.6 g/mol |
| Brands with this active ingredient | 1 | 2 |
What they share
Metoprolol and Semaglutide share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Metoprolol acts by a different mechanism than Semaglutide, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Metoprolol: Metoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate, contractility and atrioventricular conduction velocity, and lowering myocardial oxygen demand. Semaglutide: Semaglutide binds and activates the GLP-1 receptor, a G-protein coupled receptor expressed in pancreatic beta and alpha cells, the central nervous system and the gastrointestinal tract.
Indications compared
Metoprolol: Metoprolol is approved in adults for hypertension, chronic stable angina pectoris, supraventricular tachyarrhythmias and rate control in atrial fibrillation, post-myocardial infarction secondary prevention, prevention of… Semaglutide: Semaglutide is approved in adults with type 2 diabetes, as monotherapy or in combination with other antidiabetic agents, to improve glycaemic control.
Safety profile
Metoprolol: Common adverse effects include fatigue, dizziness, bradycardia, cold extremities and gastrointestinal symptoms. Semaglutide: The most common adverse effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, usually mild to moderate and tending to attenuate over weeks.
Frequently asked questions
Is Metoprolol better than Semaglutide? ▾
Metoprolol and Semaglutide are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Metoprolol and Semaglutide be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Metoprolol
Products with Semaglutide
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.